
|Articles|April 1, 1998
- Psychiatric Times Vol 15 No 4
- Volume 15
- Issue 4
Learning the Shapes
Learning the Shapes - Poetry of the Times
Advertisement
Five students
wear short white coats,
pockets bulging notecards,
tuning forks, new stethoscopes.
Demanding consent
we snap on latex gloves,
smear index fingers with K-Y,
turn them over, spread them apart
and enter alone, one by one
to learn the shapes inside:
smooth chestnut, soft orange,
stone in a muddy field.
After wiping off the jelly
we wash our hands clean,
examining fingers sensitive
as a blind bluesman
who hears each note
an instant before
touching a tight steel string.
© CME LLC
4/98
Articles in this issue
over 28 years ago
Inside Outover 28 years ago
Executing the Mentally Illover 28 years ago
SAMHSA Study Uncovers Increasing Substance Abuse Among Young Girlsover 28 years ago
Turf War: Will State Hospital Patients Suffer?over 28 years ago
Is There a Common Basis for All Addictions?over 28 years ago
New Prescription for Paraphilia?over 28 years ago
PTSD in Survivors of Rwanda's 1994 WarAdvertisement
Related to this article

Explore the urgent legal, ethical, and clinical challenges in emergency psychiatry, share cases and tips, and contribute to Psychiatric Times’ November series.

Alkermes launches a phase 2 trial of oral orexin-2 agonist ALKS 7290 to boost antidepressant response in major depressive disorder, assessing safety and symptom relief.

BCG vaccination curbs tau tangles in mice by boosting microglial cleanup, fueling hopes for human trials to reduce dementia risk.

GLP-1 weight-loss drugs may worsen eating disorders or mask symptoms; experts urge careful screening, specialist referral, and monitoring before, during, and after use.

Sabirnetug phase 2 Alzheimer trial misses cognitive endpoint despite lowering amyloid, prompting Acumen to halt development and open-label extension plans.

Psychedelic trials often exclude real-world comorbidities; clinicians must weigh blinding limits, dosing durability, support needs, safety risks, and uneven system readiness.
Advertisement
Advertisement
Trending on Psychiatric Times
1
Assessing Interventions for Insomnia in Peri- and Postmenopausal Women
2
ALKS 7290 for Adjunctive Treatment for MDD Enters Phase 2 Study
3
October 2026 in Review: Updates on the Psychiatric Treatment Pipeline, FDA News
4
GLP-1 Receptor Agonists May Reinforce Restriction in Patients With Eating Disorders
5


